Tilray Brands, Inc. (NASDAQ:TLRY) Stock Has Consensus Target Price of $5.90 According to Analysts

Shares of Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) have earned an average recommendation of “Hold” from the eight analysts that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $5.90.

Several equities research analysts have weighed in on TLRY shares. Weiss Ratings downgraded Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 23rd. Canaccord Genuity Group cut their price objective on shares of Tilray Brands from $4.50 to $4.00 and set a “hold” rating on the stock in a report on Friday, October 9th. TD Securities upgraded shares of Tilray Brands to a “strong-buy” rating in a report on Friday, July 31st. ATB Cormark Capital Markets decreased their price objective on shares of Tilray Brands from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Monday, September 21st. Finally, TD lowered their target price on shares of Tilray Brands from $4.70 to $4.50 and set a “buy” rating for the company in a research note on Monday, October 5th.

Read Our Latest Analysis on Tilray Brands

Tilray Brands Trading Down 4.3%

Shares of TLRY opened at $2.25 on Monday. Tilray Brands has a 12 month low of $2.23 and a 12 month high of $15.70. The stock has a fifty day moving average price of $3.28 and a 200-day moving average price of $5.11. The company has a current ratio of 1.88, a quick ratio of 1.11 and a debt-to-equity ratio of 0.17.

Tilray Brands (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Thursday, October 8th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.16. Tilray Brands had a negative return on equity of 10.39% and a negative net margin of 16.91%. The firm had revenue of $257.15 million for the quarter, compared to the consensus estimate of $266.26 million. On average, research analysts expect that Tilray Brands will post -0.52 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC purchased a new stake in Tilray Brands during the 2nd quarter worth approximately $27,000. Baader Bank Aktiengesellschaft lifted its position in shares of Tilray Brands by 17.7% in the first quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company’s stock valued at $293,000 after acquiring an additional 7,226 shares in the last quarter. Essential Partners LLC lifted its position in shares of Tilray Brands by 110,137.5% in the first quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock valued at $57,000 after acquiring an additional 8,811 shares in the last quarter. Swiss National Bank lifted its position in shares of Tilray Brands by 4.1% in the first quarter. Swiss National Bank now owns 230,503 shares of the company’s stock valued at $1,491,000 after acquiring an additional 9,100 shares in the last quarter. Finally, Deutsche Bank AG acquired a new stake in shares of Tilray Brands in the second quarter worth approximately $44,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray Brands

(Get Free Report)

Tilray Brands is a global cannabis and consumer packaged goods company. Its cannabis business produces and sells medical and adult-use products, including dried flower, oils, extracts and edibles, under brands such as Good Supply, Solei, Redecan and Broken Coast. The company serves customers in Canada, the United States and international markets. Its activities include medical cannabis distribution in countries where permitted, as well as cannabis and hemp-related products in North America, subject to local regulations.

See Also

Analyst Recommendations for Tilray Brands (NASDAQ:TLRY)

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.